Other adverse events with an incidence 5% are as follows: abdominal pain, headache, fatigue, dyspepsia, dizziness, abdominal distention, eructation, hypoglycemia in patients with type 2 diabetes, flatulence, gastroenteritis, gastroesophageal reflux disease, and nasopharyngitis
Despite this variability, clinical experience has established some general guidelines that providers use when transitioning patients
Lindstrom J, Louheranta A, Mannelin M, Rastas M, Salminen V, Eriksson J, et al
Unintended muscle loss, which often accompanies rapid weight loss, is another common concernand another reason why protein products are flying off shelves
Ernst & Young charts have shown that the typical IPO in Q1 2026 had ~120 employees and a median $300M post-money from investors much larger than 2016-era IPOS